as on September 6, 2025 at 1:29 am IST
Day's Low
Day's High
1.84%
Downside
1.08%
Upside
52 Week's Low
52 Week's High
55.33%
Downside
22.38%
Upside
Check Kymera Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.1B
EPS (TTM)
-3.3927
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-18.88
Industry PE ratio
-17.25
P/B Ratio
0PEG Ratio
0EBITDA
-305.1M
Revenue (TTM)
44.7M
Profit Margin
0.00%
Return On Equity TTM
26672600.00%
Track how Kymera Therapeutics Inc P/E has moved over time to understand its valuation trends.
Kymera Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 6, 2025
Today (-18.88x)
September 6, 2025
Industry (-17.25x)
September 6, 2025
Highest (0.00x)
September 6, 2025
Today’s Price to Earnings Ratio: -18.88x
Compare market cap, revenue, PE, and other key metrics of Kymera Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $3.1B | 47.24% | -18.88 | 0.00% | |
BUY | $59.2B | 267.99% | -505.15 | -12.96% | |
NA | $38.1B | NA | NA | -3.89% | |
BUY | $101.6B | 48.64% | 28.19 | 31.86% | |
BUY | $60.8B | -1.2% | 14.44 | 31.37% |
The Kymera Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kymera Therapeutics Inc investment value today
Current value as on today
₹1,00,828
Returns
₹828
(+0.83%)
Returns from Kymera Therapeutics Inc Stock
Dollar Returns*
₹4,947 (+4.95%)
Based on 23 analysts
69.57%
Buy
30.43%
Hold
0.00%
Sell
Based on 23 analysts, 69.57% of analysts recommend a 'BUY' rating for Kymera Therapeutics Inc. Average target price of $60.37
Get share price movements and forecasts by analysts on Kymera Therapeutics Inc.
What analysts predicted
27.89%UPSIDE
Target Price
$60.37
Current Price
$43.53
Analyzed by
23 Analysts
Target
$60.37
Kymera Therapeutics Inc target price $60.37, a slight upside of 27.89% compared to current price of $43.53. According to 23 analysts rating.
Search interest for Kymera Therapeutics Inc Stock has increased by 82% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:82% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, KYMR stock has moved up by 2.5%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.4% return, outperforming this stock by 89.8%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.8% return, outperforming this stock by 67.0%
Revenue Fall
Revenue is down for the last 2 quarters, 22.1M → 11.47M (in $), with an average decrease of 48.1% per quarter
Profit Down
Netprofit is down for the last 2 quarters, -65.58M → -76.61M (in $), with an average decrease of 16.8% per quarter
Organisation | Kymera Therapeutics Inc |
Headquarters | 500 North Beacon Street, Watertown, MA, United States, 02472 |
Industry | Health Technology |
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Juliet Williams B.A Ph.D. | Head of Research |
Dr. Bruce L. Booth DPHIL, Ph.D. | Co-Founder & Independent Chairman |
Mr. Bruce N. Jacobs CFA | Chief Financial Officer |
Ms. Ellen V. Chiniara Esq., J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Jared A. Gollob M.D. | Chief Medical Officer |
Ms. Justine E. Koenigsberg | Vice President of Investor Relations |
Ms. Karen Weisbach | Head of People & Culture |
Mr. Noah Goodman M.B.A. | Chief Business Officer |
Dr. Nello Mainolfi M.D., Ph.D. | Co-Founder, President, CEO & Director |
Dr. Jeremy G. Chadwick Ph.D. | Chief Operating Officer |
Kymera Therapeutics Inc share price today is $43.53 as on at the close of the market. Kymera Therapeutics Inc share today touched a day high of $44 and a low of $42.73.
Kymera Therapeutics Inc share touched a 52 week high of $53.27 on and a 52 week low of $19.45 on . Kymera Therapeutics Inc stock price today i.e. is closed at $43.53,which is 18.28% down from its 52 week high and 123.86% up from its 52 week low.
Kymera Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kymera Therapeutics Inc (KYMR) shares with as little as ₹88.143 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.43 in Kymera Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kymera Therapeutics Inc share’s latest price of $43.53 as on September 6, 2025 at 1:29 am IST, you will get 0.2297 shares of Kymera Therapeutics Inc. Learn more about
fractional shares .
Kymera Therapeutics Inc stock has given 47.24% share price returns and 19.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?